Literature DB >> 12885597

Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases.

George I Salti1, Tapas K Das Gupta.   

Abstract

BACKGROUND: The incidence of residual occult disease in nonsentinel lymph nodes (NSLN) after a positive sentinel lymph node (SLN) biopsy in patients with melanoma is relatively low. The purpose of this study is to identify factors that may be predictive of occult NSLN metastases after positive SLN biopsy.
METHODS: Fifty-six consecutive melanoma patients with positive sentinel nodes who subsequently underwent complete lymph node dissection (CLND) were evaluated.
RESULTS: Only the number of positive SLN predicted the status on NSLN by univariate (P = 0.008) and multivariate (P = 0.028) analyses. None of the other variables (characteristics of SLN metastases, number of draining nodal basins, age, sex, thickness, Clark level, ulceration, number of mitoses/mm(2), histological subtype, and location of the primary) significantly predicted CLND results.
CONCLUSIONS: Identifying patients with residual lymph node basin disease remains difficult. Thus, lymph node dissection should be performed in all patients after positive sentinel node biopsy.

Entities:  

Mesh:

Year:  2003        PMID: 12885597     DOI: 10.1016/s0002-9610(03)00169-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

Review 1.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

2.  Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.

Authors:  Rajmohan Murali; Alistair J Cochran; Martin G Cook; Joseph D Hillman; Rooshdiya Z Karim; Marc Moncrieff; Hans Starz; John F Thompson; Richard A Scolyer
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

3.  Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.

Authors:  Jeffrey E Gershenwald; Robert H I Andtbacka; Victor G Prieto; Marcella M Johnson; A Hafeez Diwan; Jeffrey E Lee; Paul F Mansfield; Janice N Cormier; Christopher W Schacherer; Merrick I Ross
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

4.  Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smears.

Authors:  Vinod B Shidham; Richard Komorowski; Marcelle Neuberg; Alonzo Walker; Bruce H Campbell; Chung-Che Chang; William W Dzwierzynski
Journal:  Diagn Pathol       Date:  2006-09-25       Impact factor: 2.644

5.  Optimization of an immunostaining protocol for the rapid intraoperative evaluation of melanoma sentinel lymph node imprint smears with the 'MCW melanoma cocktail'

Authors:  Vinod B Shidham; Richard Komorowski; Virgilia Macias; Sushma Kaul; Glen Dawson; William W Dzwierzynski
Journal:  Cytojournal       Date:  2004-08-06       Impact factor: 2.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.